# Suprascapular Nerve Block for Treatment of Shoulder Pain in Individuals With Spinal Cord Injuries

> **NCT05364099** · PHASE4 · WITHDRAWN · sponsor: **University of Miami**

## Conditions studied

- Chronic Shoulder Pain

## Interventions

- **DRUG:** Lidocaine 1% Injectable Solution
- **DRUG:** Triamcinolone Injection
- **PROCEDURE:** Suprascapular Nerve Block

## Key facts

- **NCT ID:** NCT05364099
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-11-27
- **Primary completion:** 2024-01-01
- **Final completion:** 2024-01-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to feasibly complete study.
- **Last updated:** 2023-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05364099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05364099, "Suprascapular Nerve Block for Treatment of Shoulder Pain in Individuals With Spinal Cord Injuries". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05364099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*